Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00643916Phase 2Completed
Phase 2, open-label trial of meningococcal A conjugate vaccine in meningococcal meningitis and meningococcal infection, sponsored by Sanofi. Started Dec 2004; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00643916.